Eton Pharmaceuticals, Inc. (ETON) NASDAQ
30.45
-1.41(-4.43%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
30.45
-1.41(-4.43%)
Currency In USD
| Market Cap | 455.01M |
| Enterprise Value | 460.09M |
| P/E Ratio | -563.27 |
| PEG Ratio | 44.13 |
| Price/Sales Ratio | 9.59 |
| Price/Book Ratio | 27.14 |
| Enterprise/Revenue | 9.51 |
| Enterprise/EBITDA | 145.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.02 |
| Operating Margin | 0.02 |
| Return On Assets | -0.02 |
| Return On Equity | -0.06 |
| Revenue | 79.95M |
| Revenue/Share | 3.19 |
| Gross Profit | 42.74M |
| EBITDA | 4.12M |
| Net Income | -4.6M |
| Diluted EPS | -0.17 |
| Total Cash | 19.66M |
| Total Cash/Share | 0.72 |
| Total Debt | 12.25M |
| Total Debt/Equity | 0.4 |
| Current Ratio | 1.21 |
| Book Value Per Share | 1.12 |
| 52-Week Change | 60.94 |
| 52-Week High | 35.66 |
| 52-Week Low | 13.09 |
| Moving Average 50 Days | 26.88 |
| Moving Average 200 Days | 19.7 |
| Average Volume | 416,361 |
| Shares Outstanding | 27.39M |
| % Held by Institutions | 66.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |